Aveo Pharmaceutical shares drop in trading debut
The Associated Press
NEW YORK — Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million.

and more »

Aveo Pharmaceutical shares drop in trading debut – The Associated Press

  • Comments Off
Aveo Pharmaceutical shares drop in trading debut
The Associated Press
NEW YORK — Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million.

and more »

Aveo Pharmaceutical shares drop in trading debut – The Associated Press

  • Comments Off
Aveo Pharmaceutical shares drop in trading debut
The Associated Press
NEW YORK — Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million.

and more »

Aveo Pharmaceutical shares drop in trading debut – The Associated Press

  • Comments Off
Aveo Pharmaceutical shares drop in trading debut
The Associated Press
NEW YORK — Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million.

and more »

Aveo Pharmaceutical shares drop in trading debut – The Associated Press

  • Comments Off
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results
MarketWatch (press release)
MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical

and more »

MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)

  • Comments Off
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results
MarketWatch (press release)
MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical

and more »

MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)

  • Comments Off
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results
MarketWatch (press release)
MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical

and more »

MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)

  • Comments Off
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results
MarketWatch (press release)
MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical

and more »

MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)

  • Comments Off
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results
MarketWatch (press release)
MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical

and more »

MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)

  • Comments Off
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor
MarketWatch (press release)
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for

and more »

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor … – MarketWatch (press release)

  • Comments Off